yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
.
.
.
researchers examined 1,714 samples over six months and found that just 39 per cent contained what they buyer thought they had been sold
.
.
fda commissioner: it�s not a secret, sir. many experts know about it.
.
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk.
.